Mariner’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $910K | Sell |
25,273
-9,945
| -28% | -$358K | ﹤0.01% | 1867 |
|
|
2025
Q1 | $1.39M | Buy |
35,218
+547
| +2% | +$21.6K | ﹤0.01% | 1457 |
|
|
2024
Q4 | $1.04M | Sell |
34,671
-12
| -0% | -$361 | ﹤0.01% | 1611 |
|
|
2024
Q3 | $811K | Buy |
34,683
+9,533
| +38% | +$223K | ﹤0.01% | 1766 |
|
|
2024
Q2 | $447K | Buy |
25,150
+300
| +1% | +$5.34K | ﹤0.01% | 2125 |
|
|
2024
Q1 | $378K | Hold |
24,850
| – | – | ﹤0.01% | 2243 |
|
|
2023
Q4 | $424K | Buy |
+24,850
| New | +$424K | ﹤0.01% | 2057 |
|
|
2023
Q3 | – | Sell |
-21,100
| Closed | -$524K | – | 3018 |
|
|
2023
Q2 | $524K | Hold |
21,100
| – | – | ﹤0.01% | 1705 |
|
|
2023
Q1 | $317K | Buy |
21,100
+1,500
| +8% | +$22.5K | ﹤0.01% | 2024 |
|
|
2022
Q4 | $232K | Buy |
+19,600
| New | +$232K | ﹤0.01% | 2240 |
|
|
2017
Q1 | – | Sell |
-24,116
| Closed | -$112K | – | 608 |
|
|
2016
Q4 | $112K | Sell |
24,116
-1,870
| -7% | -$8.69K | 0.01% | 542 |
|
|
2016
Q3 | $201K | Buy |
25,986
+6,900
| +36% | +$53.4K | 0.01% | 554 |
|
|
2016
Q2 | $116K | Buy |
19,086
+800
| +4% | +$4.86K | 0.01% | 517 |
|
|
2016
Q1 | $156K | Buy |
18,286
+255
| +1% | +$2.18K | 0.01% | 488 |
|
|
2015
Q4 | $215K | Buy |
18,031
+3,600
| +25% | +$42.9K | 0.01% | 404 |
|
|
2015
Q3 | $145K | Hold |
14,431
| – | – | 0.01% | 499 |
|
|
2015
Q2 | $239K | Sell |
14,431
-600
| -4% | -$9.94K | 0.01% | 455 |
|
|
2015
Q1 | $233K | Buy |
15,031
+874
| +6% | +$13.5K | 0.02% | 350 |
|
|
2014
Q4 | $224K | Buy |
+14,157
| New | +$224K | 0.02% | 342 |
|